Susquehanna International Group, LLP Catalent, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$53.58 - $57.02 $7.67 Million - $8.17 Million	-143,200 Reduced 50.32%	141,400 $7.95 Million
Q1 2024 May 07, 2024	BUY	$42.56 - $59.82 $6.74 Million - $9.48 Million	158,400 Added 125.52%	284,600 $16.1 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $10.4 Million - $15 Million	-322,100 Reduced 71.85%	126,200 $5.67 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $963,560 - $1.09 Million	21,800 Added 5.11%	448,300 $20.4 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $11.2 Million - $23.5 Million	350,000 Added 457.52%	426,500 $18.5 Million
Q1 2023 May 16, 2023	BUY	$45.44 - $74.26 $2.18 Million - $3.56 Million	48,000 Added 168.42%	76,500 $5.03 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $3.29 Million - $6.43 Million	-79,400 Reduced 73.59%	28,500 $1.28 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $253,260 - $395,850	-3,500 Reduced 3.14%	107,900 $7.81 Million

489

165M

364K

837K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.8B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.